etravirine has been researched along with hby 097 in 1 studies
| Studies (etravirine) | Trials (etravirine) | Recent Studies (post-2010) (etravirine) | Studies (hby 097) | Trials (hby 097) | Recent Studies (post-2010) (hby 097) |
|---|---|---|---|---|---|
| 572 | 90 | 321 | 22 | 5 | 0 |
| Protein | Taxonomy | etravirine (IC50) | hby 097 (IC50) |
|---|---|---|---|
| Chain A, REVERSE TRANSCRIPTASE | Human immunodeficiency virus 1 | 0.3225 | |
| Chain B, REVERSE TRANSCRIPTASE | Human immunodeficiency virus 1 | 0.3225 | |
| Chain A, REVERSE TRANSCRIPTASE | Human immunodeficiency virus 1 | 0.3225 | |
| Chain B, REVERSE TRANSCRIPTASE | Human immunodeficiency virus 1 | 0.3225 | |
| Gag-Pol polyprotein | HIV-1 M:B_HXB2R | 0.0243 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coluccia, A; La Regina, G; Silvestri, R | 1 |
1 review(s) available for etravirine and hby 097
| Article | Year |
|---|---|
Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Binding Sites; Cell Line; Drug Design; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Models, Molecular; Molecular Conformation; Nitriles; Phosphinic Acids; Pyrazoles; Pyridazines; Pyridines; Pyrimidines; Quinoxalines; Reverse Transcriptase Inhibitors; Rilpivirine | 2010 |